{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:08:46Z","timestamp":1787504926958,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jdin.2024.02.017","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T22:31:54Z","timestamp":1710196314000},"page":"206-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A randomized, controlled, split-face, double-blind comparison of a multimodality pigment-correcting serum containing lotus sprout extract versus hydroquinone for moderate to severe facial hyperpigmentation, including melasma, in a diverse population"],"prefix":"10.1016","volume":"15","author":[{"given":"Priscilla","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer F.","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul C.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdin.2024.02.017_bib1","first-page":"718","article-title":"Therapeutic insights in melasma and hyperpigmentation management","volume":"18","author":"Huerth","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib2","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2147\/CCID.S385162","article-title":"Post-inflammatory hyperpigmentation in dark skin: molecular mechanism and skincare implications","volume":"15","author":"Markiewicz","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijwd.2017.11.003","article-title":"The effect of melasma on self-esteem: a pilot study","volume":"4","author":"Jiang","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2017.05.009","article-title":"The impact of skin hyperpigmentation and hyperchromia on quality of life: a cross-sectional study","volume":"77","author":"Maymone","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14095","article-title":"The top 10 cosmeceuticals for facial hyperpigmentation","volume":"33","author":"Searle","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jdin.2024.02.017_bib6","article-title":"Evaluating the quality of life among melasma patients using the MELASQoL scale: a systematic review and meta-analysis","volume":"17","author":"Zhu","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jdin.2024.02.017_bib7","first-page":"18","article-title":"Psychosocial impact of postinflammatory hyperpigmentation in patients with acne vulgaris","volume":"10","author":"Darji","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/jocd.13182","article-title":"Melasma: a critical analysis of clinical trials investigating treatment modalities published in the past 10 years","volume":"19","author":"Spierings","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.clindermatol.2019.04.010","article-title":"Aging in skin of color","volume":"37","author":"Venkatesh","year":"2019","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib10","first-page":"s77","article-title":"Ethnicity and aging skin","volume":"16","author":"Alexis","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s13555-017-0194-1","article-title":"Melasma: an up-to-date comprehensive review","volume":"7","author":"Ogbechie-Godec","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jdin.2024.02.017_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijwd.2018.09.004","article-title":"New oral and topical approaches for the treatment of melasma","volume":"5","author":"Grimes","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"6 suppl","key":"10.1016\/j.jdin.2024.02.017_bib13","doi-asserted-by":"crossref","first-page":"AB222","DOI":"10.1016\/j.jaad.2020.06.975","article-title":"Melasma cost and factors influencing patient satisfaction [abstract 18821]","volume":"83","author":"Kim","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191912084","article-title":"Understanding melasma\u2014how can pharmacology and cosmetology procedures and prevention help to achieve optimal treatment results? A narrative review","volume":"19","author":"Pi\u0119towska","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jdin.2024.02.017_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/phpp.12783","article-title":"Melasma: the need for tailored photoprotection to improve clinical outcomes","volume":"38","author":"Morgado-Carrasco","year":"2022","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jdin.2024.02.017_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/ced.14747","article-title":"Differential diagnosis and management of hyperpigmentation","volume":"47","author":"Yoo","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib17","series-title":"Hydroquinone. StatPearls","author":"Schwartz","year":"2022"},{"key":"10.1016\/j.jdin.2024.02.017_bib18","first-page":"19","article-title":"Topical treatments for melasma and their mechanism of action","volume":"15","author":"Gonz\u00e1lez-Molina","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib19","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2021-11-2","article-title":"Dermatology: how to manage facial hyperpigmentation in skin of colour","volume":"11","author":"Moolla","year":"2022","journal-title":"Drugs Context"},{"key":"10.1016\/j.jdin.2024.02.017_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40257-016-0239-8","article-title":"Facial hyperpigmentation in skin of color: special considerations and treatment","volume":"18","author":"Vashi","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib21","first-page":"1562","article-title":"Development and clinical assessment of a comprehensive product for pigmentation control in multiple ethnic populations","volume":"15","author":"Makino","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaad.2009.10.051","article-title":"Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method","volume":"64","author":"Pandya","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-2133.2003.05419.x","article-title":"Development and validation of a health-related quality of life instrument for women with melasma","volume":"149","author":"Balkrishnan","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib24","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1111\/jocd.15165","article-title":"Pigmentation control in pregnancy-induced melasma: clinical assessment of a non-hydroquinone, non-retinol pigment-correcting serum","volume":"21","author":"Makino","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.36849\/JDD.2020.5353","article-title":"Randomized, double-blinded, split-face study comparing the efficacy and tolerability of two topical products for melasma","volume":"19","author":"Kaufman","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib26","first-page":"s21","article-title":"Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone","volume":"12","author":"Makino","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2010.12.046","article-title":"Melasma: a comprehensive update: part I","volume":"65","author":"Sheth","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib31","first-page":"376","article-title":"Assessment of circadian-based antioxidants plus a comprehensive brightener in skin of color patients with hyperpigmentation","volume":"21","author":"Desai","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib32","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1468-3083.2009.03295.x","article-title":"A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma","volume":"23","author":"Ortonne","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdin.2024.02.017_bib33","first-page":"301","article-title":"Combination of in-office chemical peels with a topical comprehensive pigmentation control product in skin of color subjects with facial hyperpigmentation","volume":"16","author":"Downie","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdin.2024.02.017_bib34","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1468-3083.2009.03251.x","article-title":"Melasma in Latin America: options for therapy and treatment algorithm","volume":"23","author":"Cestari","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdin.2024.02.017_bib35","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/jocd.14915","article-title":"Clinical assessment of a circadian-based antioxidant system combined with a comprehensive brightening serum in diverse subjects with moderate-to-severe facial hyperpigmentation","volume":"21","author":"Shah","year":"2022","journal-title":"J Cosmet Dermatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T13:44:52Z","timestamp":1717422292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328724000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S2666328724000385"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2024.02.017","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized, controlled, split-face, double-blind comparison of a multimodality pigment-correcting serum containing lotus sprout extract versus hydroquinone for moderate to severe facial hyperpigmentation, including melasma, in a diverse population","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2024.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}